Warner Chilcott plc · Dublin Ireland (NASDAQ: WCRX)
| 1 Grand Canal Sq., Docklands | Phone: +353-1-897-2000 |
| Dublin | Fax: 973-442-3283 |
| Ireland | 
Map This Company |
Warner Chilcott plc Rankings
Company Description
Warner Chilcott has a long commute. Though it's domiciled in Ireland, the pharmaceutical manufacturer's biggest market is North America where it sells brand-name drugs to the country's OB/GYNs and dermatologists. For women, Warner Chilcott makes and markets hormonal contraceptives (including Femcon FE and Loestrin), replacement hormone Estrace, and osteoporosis drug Actonel. Other principal products include acne drug Doryx, urology drug Enablex, and gastroenterology treatment Asacol. Warner Chilcott has manufacturing facilities in the US, Germany, Ireland, and Puerto Rico.
Warner Chilcott plc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: WCRX Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 2,700 |
Executives
18 executives listed for Warner Chilcott plc's Dublin, Ireland location.
| President, CEO, and Director | Roger Boissonneault | |
|---|---|---|
| EVP and CFO | Paul Herendeen | |
| EVP Corporate Development | Anthony Bruno |